Ensysce Biosciences Inc (ENSC)

Apr 01, 2025

Ensysce Biosciences corrects SEC filing omission By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Ensysce Biosciences corrects SEC filing omission - Investing.com India

Apr 01, 2025

Mar 31, 2025

Ensysce Biosciences raises $1.1 million in stock sale By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Ensysce Biosciences raises $1.1 million in stock sale - Investing.com

Mar 31, 2025

Mar 31, 2025

Ensysce Raises Fresh Capital: Strategic $1.1M Investment Powers Next-Gen Pain Drug Pipeline - Stock Titan

Mar 31, 2025

Mar 29, 2025

Ensysce Biosciences Reminds Shareholders to Vote At Upcoming 2022 Virtual Annual Shareholder Meeting - ACCESS Newswire

Mar 29, 2025

Mar 27, 2025

(ENSC) On The My Stocks Page - news.stocktradersdaily.com

Mar 27, 2025

Mar 20, 2025

Ensysce Biosciences Advances in Opioid Innovation - TipRanks

Mar 20, 2025

Mar 19, 2025

Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga

Mar 19, 2025

Mar 18, 2025

Revolutionary Opioid Safety Technology Takes Center Stage at PAINWeek 2025 - StockTitan

Mar 18, 2025

Mar 17, 2025

How the (ENSC) price action is used to our Advantage - news.stocktradersdaily.com

Mar 17, 2025

Mar 14, 2025

Zacks Small Cap Issues Negative Forecast for ENSC Earnings - Defense World

Mar 14, 2025

Mar 14, 2025

Ensysce Biosciences (ENSC) Projected to Post Earnings on Friday - Defense World

Mar 14, 2025

Mar 13, 2025

Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC) - EIN News

Mar 13, 2025

Mar 12, 2025

When Will Ensysce Biosciences, Inc. (NASDAQ:ENSC) Breakeven? - Simply Wall St

Mar 12, 2025

Mar 12, 2025

Ensysce Biosciences Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Mar 12, 2025

Mar 10, 2025

Ensysce Biosciences, Inc. SEC 10-K Report - TradingView

Mar 10, 2025

Mar 10, 2025

Ensysce Biosciences Narrows Losses to $8M, Secures FDA Breakthrough Status - StockTitan

Mar 10, 2025

Mar 06, 2025

(ENSC) Long Term Investment Analysis - Stock Traders Daily

Mar 06, 2025

Mar 05, 2025

Ensysce Biosciences to Present Pain Management Innovations at ROTH Conference - StockTitan

Mar 05, 2025

Mar 03, 2025

Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation Opioids - Marketscreener.com

Mar 03, 2025

Feb 27, 2025

Ensysce Biosciences Releases Updated Investor Presentation Available Via Investor Relations Website - ACCESS Newswire

Feb 27, 2025

Feb 20, 2025

Ensysce Biosciences Provides Business Update and Reports First Quarter 2022 Financial Results - ACCESS Newswire

Feb 20, 2025

Feb 20, 2025

Ensysce Biosciences Regains Compliance with Nasdaq - ACCESS Newswire

Feb 20, 2025

Feb 17, 2025

Ensysce Biosciences Announces Pricing of $4.1 Million Public Offering - ACCESS Newswire

Feb 17, 2025

Feb 13, 2025

How To Trade (ENSC) - Stock Traders Daily

Feb 13, 2025

Feb 05, 2025

Revolutionary Pain Management: This New Opioid Actually Prevents Overdose - StockTitan

Feb 05, 2025

Feb 04, 2025

When Can We Expect A Profit From Ensysce Biosciences, Inc. (NASDAQ:ENSC)? - Yahoo Finance

Feb 04, 2025

Jan 27, 2025

Ensysce Biosciences Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Timing of Corporate Update Call - ACCESS Newswire

Jan 27, 2025

Jan 26, 2025

Ensysce Biosciences Announces Key Efficacy Data for Lead Analgesic - ACCESS Newswire

Jan 26, 2025

Jan 26, 2025

Ensysce Biosciences Provides Key Themes Following IASP 2024 Symposium - ACCESS Newswire

Jan 26, 2025

Jan 26, 2025

Ensysce Biosciences Receives Positive Nasdaq Listing Determination - ACCESS Newswire

Jan 26, 2025

Jan 25, 2025

Ensysce Biosciences Releases Updated Investor Presentation Ahead of Corporate Update Call - ACCESS Newswire

Jan 25, 2025

Jan 25, 2025

Ensysce Biosciences Chief Medical Officer to Chair the 17th Annual Pain Therapeutics Summit - ACCESS Newswire

Jan 25, 2025

Jan 24, 2025

Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate - ACCESS Newswire

Jan 24, 2025

Jan 24, 2025

Ensysce Biosciences Receives $14 Million NIH Grant for Clinical Development of Novel Opioid with Overdose Protection - ACCESS Newswire

Jan 24, 2025

Jan 22, 2025

Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR - NEWSnet

Jan 22, 2025

Jan 22, 2025

Ensysce reports overdose protection in drug trial - Investing.com

Jan 22, 2025

Jan 22, 2025

Ensysce's PF614-MPAR Shows Breakthrough Overdose Protection in Phase 1b Opioid Trial - StockTitan

Jan 22, 2025

Jan 09, 2025

Biotech Steals The Show Following $14 Million Grant Announcement - MSN

Jan 09, 2025

Jan 08, 2025

Ensysce's Breakthrough Pain Drug Gets FDA Special Status; Secures $23.7M Funding Boost - StockTitan

Jan 08, 2025

Jan 02, 2025

Ensysce Biosciences (NASDAQ:ENSC) Shares Down 5.6% – Should You Sell? - Defense World

Jan 02, 2025

Dec 23, 2024

Ensysce Biosciences Regains Full Compliance with Nasdaq - Financial Content

Dec 23, 2024

Dec 10, 2024

Ensysce Biosciences Secures Critical Supply Deal for Breakthrough Overdose Protection Drug Development - StockTitan

Dec 10, 2024